0239 GMT - Riverstone Holdings' earnings growth prospects appear intact, based on the recovery of global semiconductor sales and improving market dynamics in the healthcare glove industry, RHB Research's Singapore Research team says in a note. Management expects sales volume growth momentum for its cleanroom gloves to persist in coming quarters, supported by continued orders from U.S. clients, the team notes. Sales volume growth momentum for the Singapore-listed company's healthcare gloves should also be underpinned by more orders from U.S. customers given potential U.S. import tariffs on China, the team adds. RHB raises the stock's target price to S$1.07 from S$1.02 with an unchanged buy rating. Shares are 1.7% higher at S$0.915. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
November 12, 2024 21:39 ET (02:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。